Turk J L, Parker D, Cameron A E
Int J Tissue React. 1984;6(3):205-11.
Cyclophosphamide (CY) given three days before immunization with a range of antigens increases the intensity of cell-mediated immune responses. CY given around the time of immunization also reverses immunological tolerance, blocks antigenic competition and modifies desensitization. The effect on antibody production is not so predictable. However, it may increase the IgE response without affecting IgG1 or IgG2 response to the same antigen and may abolish immunological memory. The action of CY is on rapidly-turning-over cell populations. Lymphocytes are maximally at risk 48 hours before they transform into large pyroninophilic cells, that is just before the S phase of cell division. CY has a preferential effect on both T- and B- suppressor cells. The application of these findings to experimental cancer models is discussed. These findings are not restricted to CY, as a wide range of cytotoxic drugs with different actions at the cellular level may have similar profound effects on the regulation of the immune response.
在用一系列抗原进行免疫接种前三天给予环磷酰胺(CY),可增强细胞介导的免疫反应强度。在免疫接种前后给予CY也可逆转免疫耐受、阻断抗原竞争并改变脱敏反应。对抗体产生的影响不太可预测。然而,它可能会增加IgE反应,而不影响对同一抗原的IgG1或IgG2反应,并且可能消除免疫记忆。CY的作用针对快速更新的细胞群体。淋巴细胞在转化为大嗜派洛宁细胞之前48小时风险最大,即在细胞分裂的S期之前。CY对T抑制细胞和B抑制细胞均有优先作用。讨论了这些发现应用于实验性癌症模型的情况。这些发现并不局限于CY,因为在细胞水平上具有不同作用的多种细胞毒性药物可能对免疫反应的调节有类似的深远影响。